COMMUNIQUÉS West-GlobeNewswire

Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results Conference Call and Webcast on Thursday, March 15th, 2018
08/03/2018
CORAL GABLES, Fla., March 08, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]
Iovance Biotherapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results and Provide a Corporate Update on Monday, March 12, 2018
08/03/2018
SAN CARLOS, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Intra-Cellular Therapies to Present at the Cowen and Company 38th Annual Health Care Conference
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today [...]
Cidara Therapeutics to Present Rezafungin Data at the European Society for Blood and Marrow Transplantation 2018 Meeting
08/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that two rezafungin abstracts [...]
Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2018
08/03/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Albireo to Report Fourth Quarter and Year-End 2017 Financial Results and Host Conference Call and Webcast on March 15, 2018
08/03/2018
BOSTON, March 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that its fourth quarter and [...]
Tyme Technologies Announces Closing of Public Offering of Common Stock
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (“Tyme” or the “Company”) announced today that, on March 6, 2018, it closed its underwritten public offering of 9,000,000 shares of [...]
Ogilvy CommonHealth Worldwide’s WLPN sponsors six rising stars to join the 2018 HBA Mentoring Program
08/03/2018
PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced that the network’s Nina [...]
UroGen Pharma to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 15, 2018
08/03/2018
Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ) today announced that it will report fourth quarter and full year [...]
Gemphire to Present at Two Investor Conferences
08/03/2018
LIVONIA, Mich., March 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
Dermira to Present at Cowen & Company 38th Annual Healthcare Conference
08/03/2018
MENLO PARK, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new [...]
BioSyent Schedules Fourth Quarter 2017 Earnings Release for March 21, 2018
08/03/2018
TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture:RX) will be reporting its financial results for the fourth quarter and fiscal year ended December 31, 2017 on Wednesday [...]
Caladrius Biosciences Reports Interim Analysis for Phase 2 T-Rex Trial of CLBS03 for Type 1 Diabetes
08/03/2018
BASKING RIDGE, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Golden Announces New Line of Cannabis Infused Fruit Chews
08/03/2018
PORTLAND, Ore., March 08, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced the [...]
Ultragenyx to Present at Upcoming Investor Conferences
08/03/2018
NOVATO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, will present [...]
Dova Pharmaceuticals to Present at Cowen 38th Annual Health Care Conference
08/03/2018
DURHAM, N.C., March 08, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Cowen 38 th [...]
Molecular Templates to Present at the Cowen and Company 38th Annual Health Care Conference
08/03/2018
AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]
HempAmericana to Uplist Shares as Company Seeks to Dominate the $2.1B CBD Oil Market
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it has begun the process of uplisting the Company’s trading [...]
Interpace Diagnostics Announces Additional Coverage of Thyroid Tests
08/03/2018
PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Pages